Zim Laboratories Ltd - Stock Valuation and Financial Performance

BSE: 541400 | NSE: ZIMLAB | Pharmaceuticals & Drugs | Small Cap

Zim Laboratories Share Price

98.40 -2.20 -2.19%
as on 18-Mar'24 16:59

DeciZen - make an informed investing decision on Zim Laboratories

Overall Rating
M-Cap below 500cr. High Risk from low Liquidity Bole Toh

1. Quality

2. Valuation

Somewhat overvalued

3. Price Trend

Zim Laboratories stock performance -

mw4me loader
P/E Ratio (SA):
30.37
Market Cap:
486 Cr.
52-wk low:
67.5
52-wk high:
151.8

Is Zim Laboratories Ltd an attractive stock to invest in?

1. Is Zim Laboratories Ltd a good quality company?

Past 10 year's financial track record analysis by Moneyworks4me indicates that Zim Laboratories Ltd is a average quality company.

2. Is Zim Laboratories Ltd undervalued or overvalued?

The key valuation ratios of Zim Laboratories Ltd's currently when compared to its past seem to suggest it is in the Somewhat overvalued zone.

3. Is Zim Laboratories Ltd a good buy now?

The Price Trend analysis by MoneyWorks4Me indicates it is Weak which suggest that the price of Zim Laboratories Ltd is likely to Fall in the short term. However, please check the rating on Quality and Valuation before investing.

10 Year X-Ray of Zim Laboratories:

Analysis of Financial Track Record

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end
Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end.

Financial track record gives insight into the company's performance on key parameters over the past ten years. MoneyWorks4me’s proprietary colour codes make it easy for retail investors to gauge the company’s past performance.
Zim Laboratories Ltd has performed well in some of the past ten years indicating its past ten year financial track record is somewhat good

Value Creation

Value Creation Index Colour Code Guide

Mar'14Mar'15Mar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23TTM
ROCE % 8%-7.7%7.3%12.7%11.3%10.2%3.9%5.1%7%10.5%-
Value Creation
Index
-0.4-1.6-0.5-0.1-0.2-0.3-0.7-0.6-0.5-0.3-

Growth Parameters

Growth Parameters Colour Code Guide

Sales 227266268235272332274304329397353
Sales YoY Gr.-17.3%0.7%-12.4%15.7%22%-17.3%10.7%8.5%20.4%-
Adj EPS 1.9-4.60.93.73.53.20.10.92.14.33.3
YoY Gr.--344.7%NA307.8%-4.4%-9.7%-98.1%1466.7%123.4%106.2%-
BVPS (₹) 24.219.620.524.5283131.232.234.939.946
Adj Net
Profit
9-22.14.317.71715.30.34.610.221.116
Cash Flow from Ops. 3.25.522.132.136.737.121.331.94735.2-
Debt/CF from Ops. 26174.42.52.22.14.22.51.11.7-

CAGR

CAGR Colour Code Guide

9 Years 5 Years 3 Years 1 Years
Sales 6.4%7.8%13.1%20.4%
Adj EPS 9.7%4.3%316.3%106.2%
BVPS5.7%7.3%8.5%14.2%
Share Price - 16.5% 55.8% 23.3%

Key Financial Parameters

Performance Ratio Colour Code Guide

Mar'14Mar'15Mar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23TTM
Return on
Equity %
8.1-214.516.313.310.70.236.311.67.6
Op. Profit
Mgn %
9.4811.113.512.512.97.212.111.512.911.3
Net Profit
Mgn %
4-8.31.67.56.24.60.11.53.15.34.5
Debt to
Equity
0.7110.70.60.50.60.50.30.3-
Working Cap
Days
22521721223322621525822522218885
Cash Conv.
Cycle
107878010489687952605836

Recent Performance Summary

Return on Equity has increased versus last 3 years average to 7.60%

Sales growth is growing at healthy rate in last 3 years 13.07%

Net Profit is growing at healthy rate in last 3 years 316.34%

Sales growth is not so good in last 4 quarters at -11.46%

Latest Financials - Zim Laboratories Ltd.

Standalone Consolidated
TTM EPS (₹) 3.3 3.4
TTM Sales (₹ Cr.) 353 355
BVPS (₹.) 46 47.4
Reserves (₹ Cr.) 175 182
P/BV 2.17 2.11
PE 30.37 29.64
From the Market
52 Week Low / High (₹) 67.45 / 151.75
All Time Low / High (₹) 14.00 / 151.75
Market Cap (₹ Cr.) 486
Equity (₹ Cr.) 48.7
Face Value (₹) 10
Industry PE 47.5

Management X-Ray of Zim Laboratories:

Shareholding Pattern

Promoter's Holding & Share Pledging

Pledged *0.000.000.000.000.000.000.000.000.000.00
* Pledged shares as % of Promoter's holding (%)

Event Update

Login/Register to view analysis.

Analyst's Notes

Key Ratios of Zim Laboratories

Adj EPS (Rs.)

Sales (Cr.)

ROE (%)

ROCE (%)

Profit And Loss

(All Figures are in Crores.)
PARTICULARSMar'14Mar'15Mar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23
Sales227266268235272332274304329397
Operating Expenses 206245239203238289255267292345
Manufacturing Costs8331413142134303845
Material Costs147162157120141160143159160199
Employee Cost 18233133414835343946
Other Costs 32273737436142435455
Operating Profit 21212932344220373851
Operating Profit Margin (%) 9.4%8.0%10.9%13.4%12.5%12.8%7.2%12.1%11.5%12.9%
Other Income 4246325256
Interest 8101410911131186
Depreciation 4799101113151516
Exceptional Items 0-33-50600-500
Profit Before Tax 13-275182423-191936
Tax 3-50-167-33611
Profit After Tax 10-225191816261325
PAT Margin (%) 4.5%-8.1%1.9%7.9%6.7%4.8%0.6%1.8%3.9%6.3%
Adjusted EPS (₹)2.1-4.51.13.93.83.30.41.22.75.1
Dividend Payout Ratio (%)8%0%16%0%4%5%0%0%0%0%

Balance Sheet

(All Figures are in Crores.)
PARTICULARSMar'14Mar'15Mar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23

Equity and Liabilities

Shareholders Fund 1169498118135150151157170194
Share Capital 888881616161649
Reserves 1088690110127134135141154145
Minority Interest0000000000
Debt80899174706277663648
Long Term Debt40383528202227221925
Short Term Debt40515647504050451723
Trade Payables47644745667266658259
Others Liabilities 21192113224023294940
Total Liabilities 264266257250294324318318337341

Fixed Assets

Gross Block8710812098113130153160174192
Accumulated Depreciation1420289192942567185
Net Fixed Assets7387928994101111103103107
CWIP 1263481310101126
Investments 0000058888
Inventories31463835525556547554
Trade Receivables98818988889063648188
Cash Equivalents 18866433822
Others Assets32383028485766705655
Total Assets 264266257250294324318318337341

Cash Flow

(All Figures are in Crores.)
PARTICULARSMar'14Mar'15Mar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23
Cash Flow From Operating Activity 352232373721324735
PBT 13-275182423-1141936
Adjustment 15512921132425252121
Changes in Working Capital -17-17-11-44-83-57-15
Tax Paid -7-2-1-2-4-1-5-10-7
Cash Flow From Investing Activity -11-9-12-7-26-23-19-6-14-35
Capex -24-15-13-9-28-18-15-6-15-36
Net Investments 00112-1-1000
Others 136000-4-3000
Cash Flow From Financing Activity 2-3-10-25-10-15-2-26-331
Net Proceeds from Shares 0000000000
Net Proceeds from Borrowing 0-3-4-5-354-4-33
Interest Paid -8-10-12-10-9-10-14-10-8-6
Dividend Paid -1-10-1-1-1-1000
Others 11115-103-99-11-223
Net Cash Flow -6-7001-10001
PARTICULARSMar'14Mar'15Mar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23
Ratios
ROE (%)9.1-20.515.3417.2714.4511.221.163.647.9613.73
ROCE (%)11.46-8.399.9714.2416.0814.964.758.1212.0217.48
Asset Turnover Ratio0.971.041.060.951.011.070.860.961.011.17
PAT to CFO Conversion(x)0.3N/A4.41.682.062.3110.55.333.621.4
Working Capital Days
Receivable Days13711911213411898102778078
Inventory Days43515555585974677259
Payable Days98125129140144158176151167130

Zim Laboratories Ltd Stock News

Zim Laboratories Ltd FAQs

Company share prices are keep on changing according to the market conditions. The closing price of Zim Laboratories on 18-Mar-2024 16:59 is ₹98.40.
Market capitalization or market cap is determined by multiplying the current market price of a company's shares with the total number of shares outstanding. As of 18-Mar-2024 16:59 the market cap of Zim Laboratories stood at ₹486.0.
The latest P/E ratio of Zim Laboratories as of 18-Mar-2024 16:59 is 30.37.
The latest P/B ratio of Zim Laboratories as of 18-Mar-2024 16:59 is 2.17.
The 52-week high of Zim Laboratories is ₹151.8 and the 52-week low is ₹67.45.
The TTM revenue is Trailing Twelve Months sales. The TTM revenue/sales of Zim Laboratories is ₹352.5 ( Cr.) .

About Zim Laboratories Ltd

ZIM Laboratories Limited is a public limited company domiciled in India engaged in the manufacturing of formulation on drugs. The company also has wholly owned subsidiaries (Zim Laboratories FZE,UAE , SIA Zim Laboratories Limited, Latvia and Zim Health Technologies Limited, India) (the Company and its subsidiaries are together referred to as 'the Group') which are engaged in manufacturing & wholesale of pharmaceutical products, market research and research & development activities.

Business area of the company

The company is engaged in the manufacturing of formulation on drugs and pre formulation on ingredients in India and marketing and selling these within and outside India.

Read More Read Less
You have 2 views remaining as a Guest User. To get DeciZen Rating of 3,500+ Stocks based on their Quality, Valuation and Price Trend Login Now
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt.Ltd.